We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Randox Laboratories

Provides global diagnostic solutions for hospital laboratories, forensic laboratories, research laboratories, pharmac... read more Featured Products: More products

Download Mobile App





Randox to Showcase Future-Proofing Diagnostic Technology at Trade Fair

By HospiMedica International staff writers
Posted on 16 Nov 2017
Print article
Image: The patented Biochip Array Technology (BAT) is designed as a multi-analyte testing platform that can currently run up to 49 assays simultaneously and 100 assays in the near future (Photo courtesy of Randox Laboratories).
Image: The patented Biochip Array Technology (BAT) is designed as a multi-analyte testing platform that can currently run up to 49 assays simultaneously and 100 assays in the near future (Photo courtesy of Randox Laboratories).
Medical diagnostics manufacturer Randox Laboratories (Crumlin, UK) will be showcasing advancements in laboratory technology at the MEDICA 2017 being held from November 13-16 in Dusseldorf, Germany. The company will announce the launch of six new products designed to improve laboratory testing and host live demonstrations of all its latest products, including Acusera 24.7, RX misano, RX Modena, Evidence Evolution and Evidence MultiSTAT.

On display at this year’s MEDICA will be Randox’s patented Biochip Array Technology (BAT), a multi-analyte testing platform that can currently run up to 49 assays simultaneously and 100 assays in the near future. This innovation allows the simultaneous quantitative or qualitative detection from a wide range of analytes from a single sample. It is suitable for use in a wide range of laboratories including clinical, research, hospital, veterinary and forensic and clinical toxicology.

Randox will also be showcasing Evidence Evolution, the world’s first fully-automated random-access biochip testing platform, capable of delivering 2640 results in one hour, with the first delivered in just 37 minutes. Joining the Evolution will be the RX Modena, a highly reliable, precise, fully automated clinical chemistry analyzer that can run 1,200 tests per hour, including ISE.

MEDICA attendees will also be among the first to experience the advancements delivered by the latest update for Randox’s Acusera 24.7. The online inter-laboratory data management and peer reporting package is designed to help laboratories efficiently review QC data from all their lab instruments on one central platform, thereby allowing quick and easy identification of QC failures and emerging trends. Updates to the software include real-time updates of peer data, more comprehensive charts and reports, bi-directional connectivity, speed improvements and a complete makeover of the dashboard.

“Through our advancements in laboratory innovation, we’re driving an industry-wide evolution” said Randox CEO, Dr Peter FitzGerald. “Our products are leading the way in innovation and enabling laboratories to transform the way they operate. We will be hosting demonstrations of a wide range of our fully automated analyzers, which are packed with cutting-edge technology and intuitive software. The goal is to provide future-proof diagnostic technology that will create the most efficient and effective laboratories.”

Randox will also feature Adiponectin, its latest weapon in the fight against cardiovascular disease, diabetes and cancers.

“We develop more new tests than any other diagnostics manufacturer, and one of the products that we’re showcasing at this year’s MEDICA is Adiponectin,” added Susan Hammond, Global Sales Manager at Randox. “This novel biomarker is a powerful new weapon in the fight against some of the biggest health issues faced throughout the world including diabetes, cancers and cardiovascular disease.”

Gold Supplier
Premium Ultrasound Scanner
ARIETTA 850
New
Medical Software
Bladder Scanner Graphics Workstation Software
New
Smart nCPAP Device
SVAAS nCPAP
New
Electric Suction Machine
YX980D

Print article

Channels

AI

view channel
Image: MyoVista Wavelet technology utilizes AI for early detection of heart disease (Photo courtesy of Heart Test Laboratories)

Novel ECG Technology Utilizes AI for Early Detection of Heart Disease

Cardiovascular disease is responsible for 17.9 million deaths every year, or about 32% of all deaths worldwide. Every week, millions of electrocardiographs (ECGs) are performed across the world, making... Read more

Critical Care

view channel
Image: Studies have shown the Autus Valve maintains control of blood flow as it expands (Photo courtesy of Boston Children’s Hospital)

Heart Valve That Grows Along With Child Could Reduce Invasive Surgeries

In children with congenital pulmonary valve disease, the flow of blood between the heart and lungs is impeded. In cases where the pulmonary valves have narrowed or are leaking and cannot be treated effectively... Read more

Surgical Techniques

view channel
Image: The LithoVue Elite System (Photo courtesy of Boston Scientific)

First Ever Ureteroscope System Monitors Intrarenal Pressure in Real-Time During Ureteroscopy Procedures

About one in 10 people can develop a kidney stone at some point in their lives. Ureteroscopy is commonly performed by urologists to diagnose and treat various problems in the urinary tract, particularly... Read more

Health IT

view channel
Image: Using digital data can improve health outcomes (Photo courtesy of Unsplash)

Electronic Health Records May Be Key to Improving Patient Care, Study Finds

When a patient gets transferred from a hospital to a nearby specialist or rehabilitation facility, it is often difficult for personnel at the new facility to access the patient’s electronic health records... Read more

Point of Care

view channel
Image: Steripath improves the diagnostic accuracy and timeliness of sepsis test results (Photo courtesy of Magnolia)

All-in-One Device Reduces False-Positive Diagnostic Test Results for Bloodstream Infections

Blood cultures are considered the gold standard diagnostic test for the detection of blood stream infections, such as sepsis. However, positive blood culture results can be frequently wrong, and about... Read more

Business

view channel
Image: The global patient positioning systems market is projected to reach USD 1.7 billion by 2027 (Photo courtesy of Pexels)

Global Patient Positioning Systems Market Driven by Increasing Chronic Diseases

The global patient positioning systems market is projected to grow at a CAGR of 4% from USD 1.4 billion in 2022 to USD 1.7 billion by 2027, driven by increasing technological advancements in medical devices,... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.